Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Uwe Siebert"'
Autor:
Beate Jahn, Nora Pashayan, Martin Widschwendter, Uwe Siebert, Nikolai Mühlberger, Ewout W. Steyerberg, Artemisa Gogollari, Gaby Sroczynski
Publikováno v:
European Journal of Health Economics, 22(8), 1311-1344. SPRINGER
European Journal of Health Economics, 22(8), 1311-1344. Springer-Verlag
European Journal of Health Economics, 22(8), 1311-1344. Springer-Verlag
Objectives: Benefit and cost effectiveness of breast cancer screening are still matters of controversy. Risk-adapted strategies are proposed to improve its benefit-harm and cost–benefit relations. Our objective was to perform a systematic review on
Autor:
Igor Stojkov, Hege Garelius, Pierre Fenaux, Marjan Arvandi, Elvira Mora, Fabio Efficace, Theo de Witte, David T. Bowen, Argiris Symeonidis, Annette Conrads-Frank, Karin A Koinig, Corine van Marrewijk, Reinhard Stauder, Fatiha Chermat, Sibylle Puntscher, Ursula Rochau, Moshe Mittelman, Uwe Siebert
Publikováno v:
Blood Advances, 6, 1-12
Blood Advances
Blood Advances, 6, 1, pp. 1-12
Blood Advances
Blood Advances, 6, 1, pp. 1-12
Key Points Systematically developed set of core PROs in MDS, involving patients and hematologists in a 2-round Delphi survey.Core PROs will support unified outcome measurement and facilitate inclusion of reliable patient information in MDS disease ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93be427965e6db74bae1cc22ed8f7bb0
http://hdl.handle.net/2066/247467
http://hdl.handle.net/2066/247467
Autor:
Gaby Sroczynski, J. Santamaria, Martin Bicher, Nikolai Mühlberger, Herwig Ostermann, Uwe Siebert, Beate Jahn, Claire Rippinger, Christoph Urach, Nikolas Popper
Publikováno v:
The European Journal of Public Health
Web of Science
Web of Science
Background The supply of COVID-19 vaccine was limited when introduced. We aimed to inform decision makers at an early stage about targeted COVID vaccination strategies, accounting for limited capacities and adherence to support vaccination prioritiza
Autor:
Igor Stojkov, Gottfried Endel, Júlia Santamaria, Maria Paulke-Korinek, Ursula Wiedermann, Günter Weiss, Christoph Urach, Nikolai Mühlberger, Beate Jahn, Nikolas Popper, Monika Redlberger-Fritz, Christiane Druml, Daniela Schmid, Caroline Czasch, Wolfgang Bock, Claire Rippinger, Gaby Sroczynski, Michael Schomaker, Herwig Ostermann, Uwe Siebert, Martin Bicher, Mirjam Kretzschmar
Publikováno v:
Vaccines
Volume 9
Issue 5
Vaccines, Vol 9, Iss 434, p 434 (2021)
Volume 9
Issue 5
Vaccines, Vol 9, Iss 434, p 434 (2021)
(1) Background: The Austrian supply of COVID-19 vaccine is limited for now. We aim to provide evidence-based guidance to the authorities in order to minimize COVID-19-related hospitalizations and deaths in Austria. (2) Methods: We used a dynamic agen
Autor:
Kenneth Bond, Daniel A. Ollendorf, Uwe Siebert, Don Husereau, Egon Jonsson, Finn Børlum Kristensen, Mirjana Huić, Jitendar Sharma, Marc L. Berger, Federico Augustovski, Michael Drummond, Alric Rüther, Maarten Joost IJzerman, John F.P. Bridges, Jeremy M. Grimshaw, Andrew Booth, Allan Wailoo
Publikováno v:
Value in health, 22(1), 13-20. Elsevier
Kristensen, F B, Husereau, D, Huić, M, Drummond, M, Berger, M L, Bond, K, Augustovski, F, Booth, A, Bridges, J F P, Grimshaw, J, IJzerman, M J, Jonsson, E, Ollendorf, D A, Rüther, A, Siebert, U, Sharma, J & Wailoo, A 2019, ' Identifying the Need for Good Practices in Health Technology Assessment : Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA ', Value in Health, vol. 22, no. 1, pp. 13-20 . https://doi.org/10.1016/j.jval.2018.08.010
Kristensen, F B, Husereau, D, Huić, M, Drummond, M, Berger, M L, Bond, K, Augustovski, F, Booth, A, Bridges, J F P, Grimshaw, J, IJzerman, M J, Jonsson, E, Ollendorf, D A, Rüther, A, Siebert, U, Sharma, J & Wailoo, A 2019, ' Identifying the Need for Good Practices in Health Technology Assessment : Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA ', Value in Health, vol. 22, no. 1, pp. 13-20 . https://doi.org/10.1016/j.jval.2018.08.010
The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of
Autor:
Ursula Rochau, D Vukicevic, Monika Buchberger, Uwe Siebert, Gaby Sroczynski, Aleksandar Savic
Publikováno v:
Medical review. 72:88-97
Introduction. Multiple myeloma is an incurable plasma-cell pro?liferation mainly affecting the elderly population. The aim of this study was to analyze treatment patterns, utilization of health resources and treatment costs of multiple myeloma in the
Autor:
Elske Ammenwerth, Stefanie Neyer, Alexander Hörbst, Gerhard Mueller, Uwe Siebert, Petra Schnell-Inderst
Publikováno v:
The Cochrane Library
Cochrane Database Syst Rev
Cochrane Database Syst Rev
Background To support patient-centred care, healthcare organisations increasingly offer patients access to data stored in the institutional electronic health record (EHR). Objectives Primary objective 1. To assess the effects of providing adult patie
Autor:
Malcolm Maclure, Sander Greenland, Judith I. Tsui, Micah Piske, Natt Hongdilokkul, Trevor Thomson, Evan Wood, Uwe Siebert, Paul Gustafson, M Ehsan Karim, Julie Bruneau, Bohdan Nosyk, Lawrence C. McCandless, M. Eugenia Socías, Robert W. Platt, Emanuel Krebs
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
BMJ Open
BMJ Open
IntroductionDespite a recent meta-analysis including 31 randomised controlled trials comparing methadone and buprenorphine for the treatment of opioid use disorder, important knowledge gaps remain regarding the long-term effectiveness of different tr
Autor:
D Vukicevic, Niki Popper, S Rajsic, Uwe Siebert, Sabine Geiger-Gritsch, Tonio Schoenfelder, Beate Jahn, Gottfried Endel, H Gothe, Diana I. Brixner
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 19, Iss 1, Pp 1-24 (2019)
BMC Health Services Research, Vol 19, Iss 1, Pp 1-24 (2019)
BackgroundChronic obstructive pulmonary disease (COPD) causes significant morbidity and mortality worldwide. Estimation of incidence, prevalence and disease burden through routine insurance data is challenging because of under-diagnosis and under-tre
Autor:
Christoph Urach, Uwe Siebert, Irmgard Schiller-Fruehwirth, G. Zauner, Patrick Einzinger, Beate Jahn
Publikováno v:
Value in Health. 20:1048-1057
Background In 2014, Austrian health authorities implemented an organized breast cancer screening program. Until then, there has been a long-standing tradition of opportunistic screening. Objectives To evaluate the cost-effectiveness of organized scre